Investigadores de ambas entidades descubren la ruta molecular que permite a estas moléculas entrar en las células endoteliales
Read more
The results show an abnormal activation of the first immune response against the virus and a reduced neutralizing antibody response. Identifying these mechanisms could open the door to new therapeutic...
Read more
A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a...
Read more
A study reveals that this chromosomal instability caused by hyperdiploidy reduces the proliferation of the affected cells, delays their differentiation and allows some to persist as rare, long-lived c...
Read more
En este artículo analizan las principales tendencias actuales en inmunoterapia y el papel que los anticuerpos siguen desempeñando tanto en investigación básica como en desarrollo preclínico y tra...
Read more
GTX-11, developed by GAT Therapeutics and protected by patent, is a small oral molecule that modulates the TGFβ signalling pathway, a key factor in fibrotic processes, characterised by the excessive ...
Read more
La Dra. Marta Alonso lidera el proyecto de un nuevo virus oncolítico contra los gliomas de línea media difusa y el Dr. Iñaki Eguren investigará en el Reino Unido la respuesta del carcinoma renal a...
Read more
Con los años, las mujeres presentan una mayor predisposición a enfermedades autoinmunes, mientras que en los hombres aumenta el riesgo de determinados cánceres de la sangre. Un nuevo estudio analiz...
Read more
It has been shown in various animal cancer models that the administration of DNA-loaded lipid nanoparticles has a powerful anti-tumour effect and, furthermore, can significantly enhance the activity o...
Read more
Exploran cómo los AbyPanels de Abylabel, kits que incluyen varios anticuerpos dirigidos contra un mismo target en volúmenes reducidos, permiten llevar a cabo esta validación de forma más eficiente...
Read more
MEDINA participates in the NOVA-VRE project to develop new therapies to combat antibiotic-resistant bacteria.
Read more
A nanoparticle developed at the UPV opens up a new approach to fighting cancer: it restores communication between tumour cells and immune cells, enabling the latter to eliminate cancer cells
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
